Revised SPCs: Eldepryl (selegiline hydrochloride) Tablets – all strengths

SPCs updated to include risk of serotonin syndrome with concomitant administration of selegiline hydrochloride and buprenorphine/opioids, which may result in a potentially life-threatening condition.

Source:

electronic Medicines compendium